Company Overview of Selecta Biosciences, Inc.
Selecta Biosciences, Inc. is a clinical-stage biotechnology company that develops targeted immunotherapies and vaccines that regulate immune responses to prevent and treat diseases. The company provides synthetic vaccine particles (SVP) therapies that are applied in various therapeutic areas with a focus on the inhibition of immunogenicity for protein therapies, treatment of allergies, and treatment of autoimmune diseases. Its SVP therapies prevent effects of anti-drug antibodies caused by the immunogenicity of biologic drugs in patients. The company develops antigen-specific tolerogenic SVPs to prevent and suppress pro-inflammatory responses against a specific antigen for the inhibition of ...
480 Arsenal Street
Watertown, MA 02472
Founded in 2007
Key Executives for Selecta Biosciences, Inc.
Chief Executive Officer, President and Director
Founder, Vice Chairman and Member of The Scientific Advisory Board
Co-Founder and Co-Chair of the Scientific Advisory Board
Co-Founder, Co-Chair of the Scientific Advisory Board and Director
Vice President of Finance
Compensation as of Fiscal Year 2015.
Selecta Biosciences, Inc. Key Developments
Selecta Biosciences, Inc. Appoints Earl (‘Skip’) Sands, MD, as Chief Medical Officer
Sep 8 15
Selecta Biosciences, Inc. announced the appointment of Earl (‘Skip’) Sands, MD, as Chief Medical Officer (CMO). As CMO, Dr. Sands will oversee all clinical development and regulatory activities for the company, as Selecta rapidly advances its product candidates in and toward human clinical trials for a range of diseases, including refractory gout, gene therapy, smoking cessation, human papillomavirus (HPV) associated cancers, and others. He will report directly to Selecta’s CEO Werner Cautreels, PhD, and will serve as a member of the company’s executive management team.
Selecta Biosciences Mulls IPO In Future
Sep 8 15
Selecta Biosciences, Inc. would explore an initial public offering (IPO) in future. Werner Cautreels, Chief Executive Officer of the company said “Clearly it’s something we’ll explore.”
Selecta Biosciences, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 02:00 PM
Jun 18 15
Selecta Biosciences, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 02:00 PM. Venue: Le Parker Meridien Hotel, 119 W. 56th Street, New York, NY 10019, United States. Speakers: Werner Cautreels, Chief Executive Officer, President and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
August 27, 2015
April 10, 2015